198 related articles for article (PubMed ID: 36539545)
1. Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis.
Zhu Z; Jiang H; Xie J; Jin X; Li B; Liu J
Sci Rep; 2022 Dec; 12(1):22016. PubMed ID: 36539545
[TBL] [Abstract][Full Text] [Related]
2. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Expression Levels of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Gastric Cancer: a Meta-Analysis.
Zhao G; Wu Y; Wu L; Huang J; Gan Y; Li H
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865259
[TBL] [Abstract][Full Text] [Related]
4. Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review.
Wang H; Shan X; Peng Y; Zhou W
Drug Dev Res; 2023 Aug; 84(5):805-814. PubMed ID: 37114737
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of circular RNAs in the diagnosis, prognosis and clinicopathological features of thyroid cancer: A systematic review and meta-analysis.
Zhu C; Feng Z; Hong F; Sun H; Wang Z; Zhao Z; Zhang F
Pathol Res Pract; 2022 Aug; 236():153871. PubMed ID: 35797852
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic values of circular RNAs for lung cancer: a meta-analysis.
Yang Q; Chen L; Yang L; Huang Y
Postgrad Med J; 2021 May; 97(1147):286-293. PubMed ID: 32518074
[TBL] [Abstract][Full Text] [Related]
7. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.
Foruzandeh Z; Dorabadi DG; Sadeghi F; Zeinali-Sehrig F; Zaefizadeh M; Rahmati Y; Alivand MR
Mol Biol Rep; 2022 Oct; 49(10):9825-9840. PubMed ID: 35534586
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis.
Yuan J; Guo D; Li X; Chen J
BMC Cancer; 2020 May; 20(1):448. PubMed ID: 32429931
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta-analysis.
Guo C; Mi J; Li H; Su P; Nie H
Cancer Med; 2021 Nov; 10(22):7895-7908. PubMed ID: 34704390
[TBL] [Abstract][Full Text] [Related]
10. CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.
Chu M; Fang Y; Jin Y
J Clin Lab Anal; 2021 Sep; 35(9):e23934. PubMed ID: 34331339
[TBL] [Abstract][Full Text] [Related]
11. CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis.
Ding X; Yang L; Geng X; Zou Y; Wang Z; Li Y; Qi R; Wang W; Li J; Yu H
BMC Cancer; 2020 Oct; 20(1):1005. PubMed ID: 33059605
[TBL] [Abstract][Full Text] [Related]
12. CircRNAs as promising biomarker in diagnostic and prognostic of lung cancer: An updated meta-analysis.
Yang X; Tian W; Wang S; Ji X; Zhou B
Genomics; 2021 Jan; 113(1 Pt 1):387-397. PubMed ID: 33326833
[TBL] [Abstract][Full Text] [Related]
13. Influence of dysregulated expression of circular RNA on the diagnosis and prognosis of breast cancer in Asia: a meta-analysis study.
Liu F; Wu X; Zhu H; Wang F
BMJ Open; 2021 Nov; 11(11):e044267. PubMed ID: 34728436
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
Hao Q; Han Y; Xia W; Wang Q; Qian H
Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
Zhong J; Zhang G; Yao W
J Orthop Surg Res; 2021 Oct; 16(1):578. PubMed ID: 34620208
[TBL] [Abstract][Full Text] [Related]
16. circRNAs in drug resistance of breast cancer.
Misir S; Yaman SO; Petrović N; Sumer C; Hepokur C; Aliyazicioglu Y
Oncol Res; 2022; 30(4):157-172. PubMed ID: 37304411
[TBL] [Abstract][Full Text] [Related]
17. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.
Madurantakam Royam M; Kumarasamy C; Baxi S; Gupta A; Ramesh N; Kodiveri Muthukaliannan G; Jayaraj R
Mol Diagn Ther; 2019 Feb; 23(1):65-82. PubMed ID: 30726546
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Expression of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Cancer.
Huang X; Zhang Z; Qing X; Zhang W; Zhong B; Deng X; Wang S; Cheng C; Hu H; Shao Z
J Cancer; 2019; 10(8):1825-1832. PubMed ID: 31205539
[No Abstract] [Full Text] [Related]
19. Circular RNA; a new biomarker for breast cancer: A systematic review.
Jahani S; Nazeri E; Majidzadeh-A K; Jahani M; Esmaeili R
J Cell Physiol; 2020 Jul; 235(7-8):5501-5510. PubMed ID: 31985056
[TBL] [Abstract][Full Text] [Related]
20. Circular RNAs are Potential Prognostic Markers of Head and Neck Squamous Cell Carcinoma: Findings of a Meta-Analysis Study.
Nath M; Roy D; Choudhury Y
Front Oncol; 2022; 12():782439. PubMed ID: 35296016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
